Cover Image

Minding Averages: Comment on “Experimental Design and Power Calculation in Omics Circadian Rhythmicity Detection Using the Cosinor Model” by Zong et al.

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Author:	Pål O. Westermark
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	Statistics in Medicine
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Response to the Commentary on “Experimental Design and Power Calculation in Omics Circadian Rhythmicity Detection Using the Cosinor Model”
by: RuoFei Yin, et al.
Published: (2025)

Weighted Trigonometric Regression for Suboptimal Designs in Circadian Transcriptome Studies
by: Michael T. Gorczyca, et al.
Published: (2025)

Authors' Response to Comments by Di Tanna et al.
by: Heejung Bang, et al.
Published: (2026)

Sample Size Calculation for the ROCI Design
by: Henry Bern, et al.
Published: (2026)

Integrating Multiple Data Sources With Interactions in Multi‐Omics Using Cooperative Learning
by: Matteo D'Alessandro, et al.
Published: (2025)

Sample Size and Power Calculations With Win Measures Based on Hierarchical Endpoints
by: Huiman Barnhart, et al.
Published: (2025)

Sample Size Calculation in Dose Optimization Trials Using the Margin of Practical Non‐Inferiority
by: Hakim‐Moulay Dehbi, et al.
Published: (2025)

Comments on “Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods”
by: M. C. Donohue, et al.
Published: (2025)

Comments on “Sample Size Adaptation Designs and Efficiency Comparison With Group Sequential Designs”
by: Meinhard Kieser, et al.
Published: (2025)

A Causal Perspective on “Appropriate Implementation of ICH E9 ( R1 ) Addendum Strategies” (Comment on Fleming et al.)
by: Tim P. Morris, et al.
Published: (2026)

Power and Sample Size Calculations for Cluster Randomized Hybrid Type 2 Effectiveness‐Implementation Studies
by: Melody A. Owen, et al.
Published: (2025)

Two‐Stage Drop‐the‐Losers Design for the Selection of Effective Treatments and Estimating Their Average Worth
by: Yogesh Katariya, et al.
Published: (2025)

Instrumental Variable Model Average With Applications in Nonlinear Causal Inference
by: Dong Chen, et al.
Published: (2024)

Integrating Omics and Pathological Imaging Data for Cancer Prognosis via a Deep Neural Network‐Based Cox Model
by: Jingmao Li, et al.
Published: (2026)

Overcoming Model Uncertainty — How Equivalence Tests Can Benefit From Model Averaging
by: Niklas Hagemann, et al.
Published: (2025)

Expected Value of Sample Information Calculations for Risk Prediction Model Development
by: Abdollah Safari, et al.
Published: (2026)

Simultaneous Representation Learning of Multi‐Omics and Clinical Outcome Data via a Supervised Knowledge‐Guided Bayesian Factor Model
by: Qiyiwen Zhang, et al.
Published: (2026)

Multivariate Adjustments for Average Equivalence Testing
by: Younes Boulaguiem, et al.
Published: (2025)

Reconciling Binary Replicates: Beyond the Average
by: H. Lorenzo, et al.
Published: (2026)

Integrative Multi‐Omics and Multivariate Longitudinal Data Analysis for Dynamic Risk Estimation in Alzheimer's Disease
by: Yuanyuan Guo, et al.
Published: (2025)

A Sensitivity Analysis Framework Using the Proxy Pattern–Mixture Model for Generalization of Experimental Results
by: Rebecca R. Andridge, et al.
Published: (2025)

Estimating Average Treatment Effects With Support Vector Machines
by: Alexander Tarr, et al.
Published: (2025)

Response to Letter to the Editor “Comments on ‘Novel Non‐Linear Models for Clinical Trial Analysis With Longitudinal Data: A Tutorial Using SAS for Both Frequentist and Bayesian Methods’”
by: Guoqiao Wang, et al.
Published: (2025)

Matching‐Based Nonparametric Estimation of Group Average Treatment Effects
by: Peng Wu, et al.
Published: (2026)

Improved Pharmacovigilance Signal Detection Using Bayesian Generalized Linear Mixed Models
by: Paloma Hauser, et al.
Published: (2025)

A Novel Stratified Analysis Method for Testing and Estimating Overall Treatment Effects on Time‐To‐Event Outcomes Using Average Hazard With Survival Weight
by: Zihan Qian, et al.
Published: (2025)

Identification and Estimation of the Average Causal Effects Under Dietary Substitution Strategies
by: Yu‐Han Chiu, et al.
Published: (2025)

Regional Consistency Evaluation and Sample Size Calculation Under Two MRCTs
by: Kunhai Qing, et al.
Published: (2025)

A Model Based on Mixture of Weibull Distributions for Depending Competing Risks Data in the Presence of Long‐Term Survivors, and Its Application to Malignant Melanoma Cancer Data
by: Ayon Ganguly, et al.
Published: (2026)

A Bayesian Approach to Estimate Causal Average Treatment Effects Under Unmeasured Confounding
by: Jinghong Zeng
Published: (2026)

A Precision Mixture Risk Model to Identify Adverse Drug Events in Subpopulations Using a Case‐Crossover Design
by: Yi Shi, et al.
Published: (2024)

Tuning LASSO Models for Propensity Score Weighting and Using Synthetic Negative Control Exposures for Residual Bias Detection
by: Richard Wyss, et al.
Published: (2026)

Bayesian Borrowing With Multiple Heterogeneous Historical Studies Using Order Restricted Normalized Power Prior
by: Zifei Han, et al.
Published: (2025)

Group Sequential Trial Design Using Stepwise Monte Carlo for Increased Flexibility and Robustness
by: Amitay Kamber, et al.
Published: (2025)

Statistical Inference for a Two‐Stage Adaptive Seamless Design Using Different Binary Endpoints
by: Ryota Ishii, et al.
Published: (2025)

Sample Size Re‐Estimation in Blinded Hybrid‐Control Design Using Inverse Probability Weighting
by: Masahiro Kojima, et al.
Published: (2026)

Dirichlet Distribution Parameter Estimation With Applications in Microbiome Analyses
by: Daniel T. Fuller, et al.
Published: (2026)

Adaptive Sparsening and Smoothing of the Treatment Model for Longitudinal Causal Inference Using Outcome‐Adaptive LASSO and Marginal Fused LASSO
by: Mireille E. Schnitzer, et al.
Published: (2026)

On Inclusion of Covariates in Model Based Dose Finding Clinical Trial Designs
by: Adrien Ollier, et al.
Published: (2025)

Commentary on Fleming et al. “A Perspective on the Appropriate Implementation of ICH E9 ( R1 ) Addendum Strategies for Handling Intercurrent Events”
by: Oliver Keene, et al.
Published: (2026)